Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8684)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2020 (publication date) through Jul 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen YH, Xiao J, Chen XJ, Wang HS, Liu D, Xiang J, Peng JS. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World J Gastroenterol 2020; 26(19): 2427-2439 [PMID: 32476803 DOI: 10.3748/wjg.v26.i19.2427] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v26/i19/2427.htm |
| Number | Citing Articles |
| 1 |
Xiao-Huan Tang, Xiao-Long Wu, Xue-Jun Gan, Yi-Ding Wang, Fang-Zhou Jia, Yi-Xue Wang, Yan Zhang, Xiang-Yu Gao, Zi-Yu Li. Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. International Journal of Molecular Sciences 2023; 24(15): 12192 doi: 10.3390/ijms241512192
|
| 2 |
Han Shao, Nai Li, Yi‐hong Ling, Ji‐jin Wang, Yi Fang, Ming Jing, Zhi‐wei Zhou, Yu‐jing Zhang. Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trial. Cancer Medicine 2024; 13(6) doi: 10.1002/cam4.7122
|
| 3 |
Qing Hu, Jian Wang, Wei‐Guo Xu, Peng Shao, Gang Li. Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy. Precision Medical Sciences 2021; 10(2): 78 doi: 10.1002/prm2.12038
|
| 4 |
Annamaria Agnes, Luca Boldrini, Federica Perillo, Huong Elena Tran, Maria Gabriella Brizi, Riccardo Ricci, Jacopo Lenkowicz, Claudio Votta, Alberto Biondi, Riccardo Manfredi, Vincenzo Valentini, Domenico M. D’Ugo, Roberto Persiani. Radiomic-based models are able to predict the pathologic response to different neoadjuvant chemotherapy regimens in patients with gastric and gastroesophageal cancer: a cohort study. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03828-9
|
| 5 |
Daniel Skubleny, Andrea Lin, Saurabh Garg, Ross McLean, Michael McCall, Sunita Ghosh, Jennifer L Spratlin, Daniel Schiller, Gina Rayat. Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study. World Journal of Gastrointestinal Oncology 2023; 15(2): 303-317 doi: 10.4251/wjgo.v15.i2.303
|
| 6 |
Bing Liu, Yu-Jie Xu, Feng-Ran Chu, Guang Sun, Guo-Dong Zhao, Sheng-Zhong Wang. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World Journal of Gastrointestinal Surgery 2024; 16(2): 396-408 doi: 10.4240/wjgs.v16.i2.396
Abstract(520) |
Core Tip(483) |
Full Article(HTML)(1495)
|
Full Article with Cover (PDF)-1256K(122)
|
Full Article (Word)-536K(6)
|
Audio-2572K(4)
|
Peer-Review Report-227K(72)
|
Answering Reviewers-76K(82)
|
Full Article (PDF)-999K(105)
|
Full Article (XML)-145K(75)
|
Times Cited (2)
|
Total Visits (5857)
|
Open
|
| 7 |
Kamil Nurczyk, Norbert Nowak, Rebecca Carlson, Tomasz Skoczylas, Grzegorz Wallner. Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: A systematic review and meta-analysis. Advances in Medical Sciences 2023; 68(1): 138 doi: 10.1016/j.advms.2023.02.005
|
| 8 |
Yonghe Chen, Jiasheng He, Jiabo Zheng, Yi Lin, Huashe Wang, Lei Lian, Junsheng Peng. Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03594-8
|
| 9 |
Zining Liu, Yinkui Wang, Fei Shan, Xiangji Ying, Yan Zhang, Shuangxi Li, Yongning Jia, Rulin Miao, Kan Xue, Zhemin Li, Ziyu Li, Jiafu Ji. Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01785-7
|
| 10 |
Chenchen Liu, Liming Li, Xingzhi Chen, Chencui Huang, Rui Wang, Yiyang Liu, Jianbo Gao. Intratumoral and peritumoral radiomics predict pathological response after neoadjuvant chemotherapy against advanced gastric cancer. Insights into Imaging 2024; 15(1) doi: 10.1186/s13244-023-01584-6
|
| 11 |
Zhihao Zhou, Yong Ren, Zhimei Zhang, Tianpei Guan, Zhixiong Wang, Wei Chen, Tedong Luo, Guanghua Li. Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer. Gastric Cancer 2023; 26(5): 734 doi: 10.1007/s10120-023-01407-z
|
| 12 |
Haiyu Wang, Yumin Ding, Min Zhuang, Kaixu Li, Shujing Zhao, Dehong Li. Application and progress of nomograms in gastric cancer. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1510742
|
| 13 |
Yonghe Chen, Dan Liu, Jian Xiao, Jun Xiang, Aihong Liu, Shi Chen, Junjie Liu, Xiansheng Hu, Junsheng Peng, Fausto Rosa. Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/2923700
|
| 14 |
Xian-Wen Liang, Wei-Sheng Xiao, Hao Lei, Qian-Cheng Huag, Yu-Lan Dong, Fang Wang, Wei-Peng Qing. Risk model and factors for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer-a two-center cohort study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10513-1
|
| 15 |
Chunjing Wang, Zhen Wang, Yue Zhao, Fujing Wang. Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study. Journal of Gastric Cancer 2023; 23(2): 328 doi: 10.5230/jgc.2023.23.e17
|
| 16 |
Ling-Kang Zhang, Hua-Long Zheng, Hong-Hong Zheng, Yu-Bin Ma, Jian-Xian Lin, Bin-Bin Xu, Zhen Xue, Zhi-Wei Zheng, Chao-Hui Zheng, Chang-Ming Huang, Jian-wei Xie. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy. European Journal of Surgical Oncology 2024; 50(6): 108367 doi: 10.1016/j.ejso.2024.108367
|
| 17 |
Gang Wang, Hua-Long Zheng, Ling-Kang Zhang, Yu-Qin Sun, Bao-Long Li, Yong-Hong Wang, Ju Wu, Shi-Chao Wu, Hong-Hong Zheng, Zhen Xue, Cai-Ming Weng, Jian-Xian Lin, Ji-Ao Tang, Jia-Bin Wang, Chang-Ming Huang. Appraisal of Residual Tumor Burden on Survival Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Multicenter Cohort Study. Annals of Surgical Oncology 2025; doi: 10.1245/s10434-025-17601-5
|
| 18 |
Ti-Hong Qiu, Hong-You Wen, Yi-Long Huang. Significance of hemoglobin and hematocrit changes in predicting patient survival and efficacy of neoadjuvant chemotherapy for advanced gastric cancer. World Journal of Gastrointestinal Oncology 2025; 17(6): 104592 doi: 10.4251/wjgo.v17.i6.104592
|
| 19 |
Yonghe Chen, Dan Liu, Kaikai Wei, Yi Lin, Zhong Wang, Qian Sun, Huashe Wang, Junsheng Peng, Lei Lian. Carcinoembryonic antigen trajectory predicts pathological complete response in advanced gastric cancer after neoadjuvant chemotherapy. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1525324
|